MAY282025_02B5203Decided 2025-05-28I-140

A biostatistics researcher's EB-1A appeal was sustained after the AAO found the petitioner met five evidentiary…

Sustained Useful for: avoid these mistakes
EB-1AField: statistical genetics researcher specializing in biostatistics, a field that uses statistical methods to study genetics
The outcome

This appeal was fully successful

The AAO sustained the appeal, finding the petitioner met five of the ten evidentiary criteria (judging, original contributions, scholarly articles, leading role, and high salary) and demonstrated extraordinary ability in the final merits determination based on the totality of evidence.

5 / 3 criteria needed Threshold cleared ✓

Next step: a full merits review weighing all the evidence together.

In plain English

A statistical genetics researcher specializing in biostatistics appealed the denial of his EB-1A extraordinary ability petition. SCOPS had found three criteria met (judging, original contributions, scholarly articles) but denied two others (leading/critical role and high salary) and concluded the petitioner failed the final merits determination. The AAO reversed on both denied criteria: it found SCOPS wrongly ignored detailed letters about the petitioner's critical roles at a major pharmaceutical company, and improperly required salary comparisons to match the petitioner's specific internal job title. Reviewing the full record de novo, the AAO found compelling evidence that the petitioner's statistical methods have become gold standards adopted by researchers worldwide, his articles consistently rank in the top-cited papers in the field, and his tools have been used in major international genetic studies. The appeal was sustained and the petition approved.

What worked & what failed

What worked: 1. Letters of support from supervisors and collaborators at a major multinational pharmaceutical company provided specific, detailed descriptions of the petitioner's leading and critical roles and the company's use of his methods, which the AAO found persuasive for the leading/critical role criterion. 2. Salary documentation using BLS, DOL, and compensation website data showing earnings at or above the highest ranges for comparable positions was accepted as sufficient for the high salary criterion, even though it was not specific to the petitioner's exact internal job title. 3. The totality of evidence—including citation impact (top 1% and 10% papers), adoption of methods as 'gold standards,' international use in multi-country studies, and federally funded research—demonstrated sustained national and international acclaim for the final merits determination.

What failed: 1. SCOPS' approach of requiring salary comparisons to match the petitioner's specific internal job title rather than comparable market positions was found legally erroneous. 2. SCOPS' initial dismissal of letters supporting the leading/critical role criterion was found to have ignored the detailed content of those letters and the distinguished nature of the employing organization.

Takeaway: When documenting a leading or critical role, ensure letters of support explicitly describe both the nature of the role and the distinguished status of the organization. For the high salary criterion, do not rely solely on job-title-specific data—use widely recognized sources like BLS and DOL to demonstrate compensation relative to the broader field, as internal job titles may be unique to the employer.

For RFE responses & petition building

Cases like this are frequently used by attorneys when responding to RFEs or building initial petitions. The evidence patterns that worked (or failed) here directly reflect what USCIS officers look for when evaluating EB-1A criteria.

Evidence that moved the needle

  • Letters of support from supervisors and collaborators at a major multinational pharmaceutical company provided specific, detailed descriptions of the petitioner's leading and critical roles and the company's use of his methods, which the AAO found persuasive for the leading/critical role criterion
  • Salary documentation using BLS, DOL, and compensation website data showing earnings at or above the highest ranges for comparable positions was accepted as sufficient for the high salary criterion, even though it was not specific to the petitioner's exact internal job title
  • The totality of evidence—including citation impact (top 1% and 10% papers), adoption of methods as 'gold standards,' international use in multi-country studies, and federally funded research—demonstrated sustained national and international acclaim for the final merits determination.

Evidence that wasn't enough alone

  • SCOPS' approach of requiring salary comparisons to match the petitioner's specific internal job title rather than comparable market positions was found legally erroneous
  • SCOPS' initial dismissal of letters supporting the leading/critical role criterion was found to have ignored the detailed content of those letters and the distinguished nature of the employing organization.
Find more EB-1A cases with similar evidence patterns →
What the evidence showed

Criterion-by-criterion breakdown

Judging the work of others

Met

SCOPS found this criterion met; petitioner served as peer reviewer for over forty articles in high-ranking, high-impact medical publications and served on an editorial board.

Original contributions of major significance

Met

SCOPS found this criterion met; petitioner developed widely-adopted statistical methods described as 'gold standards' in biostatistical analysis.

Authorship of scholarly articles

Met

SCOPS found this criterion met; petitioner authored/co-authored peer-reviewed articles in top-ranked journals, with five in the top 10% and two in the top 1% of most-cited papers.

Leading or critical role for distinguished organizations

Reversed in their favor

SCOPS denied this criterion, but AAO reversed, finding letters of support provided sufficient detail about petitioner's leading and critical roles at a major multinational pharmaceutical company generating tens of billions in annual revenue.

High salary or other significantly high remuneration

Reversed in their favor

SCOPS denied this criterion because it inappropriately confined analysis to petitioner's specific internal job title; AAO reversed, finding BLS and DOL data showed petitioner's earnings met or exceeded highest salary ranges nationally and locally for comparable positions.

Evidence that persuaded the AAO

Letters from directors and supervisors at a major multinational pharmaceutical company detailing petitioner's leading and critical roles in developing state-of-the-art statistical techniques

Bureau of Labor Statistics and Department of Labor compensation data showing petitioner's earnings met or exceeded highest salary ranges nationally and locally

Peer-reviewed articles in top-ranked journals, with five ranked in top 10% and two in top 1% of most-cited papers in their respective years

Evidence of petitioner's statistical methods being adopted as 'gold standards' in biostatistical analysis internationally

Letters from researchers at prominent institutions worldwide describing use of petitioner's methods in their own studies

Evidence of petitioner's tools being used in studies involving researchers from multiple countries including the UK, Finland, Italy, Netherlands, Germany, Denmark, Belgium, and Australia

Federal government-funded research projects totaling hundreds of thousands of dollars with petitioner as first author or co-author

Peer review activity for over forty articles in high-ranking, high-impact publications including editorial board membership

Where the evidence fell short

SCOPS initially found letters of support for the leading/critical role criterion insufficient for lacking specificity about the distinguished nature of organizations and the leading/critical nature of the roles (reversed by AAO)

SCOPS initially found salary comparison data insufficient because it was not specific to petitioner's exact job title (reversed by AAO)

Officer errors the AAO found

SCOPS incorrectly found the criterion VIII (leading or critical role) unmet by failing to adequately consider detailed letters of support describing the petitioner's roles at a distinguished multinational pharmaceutical company.

SCOPS improperly confined the salary comparison to the petitioner's specific internal job title rather than comparable positions in the field, leading to an erroneous denial of criterion IX (high salary).

SCOPS' final merits determination failed to consider the petition in its totality and did not appropriately weigh all submitted evidence.

How the case moved

Completed

I-140 filed

Biostatistics researcher specializing in statistical genetics, developing statistical methods and tools used in genetic studies and pharmaceutical research

Completed

SCOPS — Denied

Initial decision: Denied.

Completed

Appeal to the AAO

Petitioner appealed to the Administrative Appeals Office for de novo review.

2025-05-28

AAO decision — Sustained

The AAO sustained the appeal, finding the petitioner met five of the ten evidentiary criteria (judging, original contributions, scholarly articles, leading role, and high salary) and demonstrated extraordinary ability in the final merits determination based on the totality of evidence.

Find this useful? A coffee helps keep Case Reviewer free and ad-free.

Buy me a coffee
Authorities the office relied on
8 C.F.R. § 204.5(h)(2)8 C.F.R. § 204.5(h)(3)8 C.F.R. § 204.5(h)(3)(i)-(x)8 C.F.R. § 204.5(h)(3)(iv)8 C.F.R. § 204.5(h)(3)(v)8 C.F.R. § 204.5(h)(3)(vi)8 C.F.R. § 204.5(h)(3)(viii)8 C.F.R. § 204.5(h)(3)(ix)8 C.F.R. § 103.3
ChawathePetitioner bears the burden of proof to demonstrate eligibility by a preponderance of the evidence.
Christo'sAAO reviews questions de novo.
KazarianEstablishes the two-step review framework: first count qualifying criteria, then conduct a final merits determination in context of sustained acclaim.
VisinscaiaSupports the Kazarian two-part review framework.
RijalSupports the Kazarian two-part review framework.
PriceCited in support of the final merits determination finding extraordinary ability.
H.R. Rep. 101-172Congressional intent that extraordinary ability is demonstrated through a 'career of acclaimed work in the field.'